 | • レポートコード：MRC2Q12-19229 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、メスコポラミン臭化物のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 メスコポラミン臭化物のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 メスコポラミン臭化物の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 メスコポラミン臭化物のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのメスコポラミン臭化物の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のメスコポラミン臭化物の売上および2028年までの予測に焦点を当てています。 メスコポラミン臭化物のグローバル主要企業には、Aldo Union、Bayshore Pharma、Beltapharm、Breckenridge Pharma、Novartis、Strides Pharma、Guangzhou Pharmaceutical Groupなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 メスコポラミン臭化物市場は、タイプとアプリケーションによって区分されます。世界のメスコポラミン臭化物市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 5mg、2.5mg、1mg 【アプリケーション別セグメント】 術後悪心・嘔吐、乗り物酔い、腹痛、過敏性腸症候群、目の炎症、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - メスコポラミン臭化物製品概要 - タイプ別市場（5mg、2.5mg、1mg） - アプリケーション別市場（術後悪心・嘔吐、乗り物酔い、腹痛、過敏性腸症候群、目の炎症、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のメスコポラミン臭化物販売量予測2017-2028 - 世界のメスコポラミン臭化物売上予測2017-2028 - メスコポラミン臭化物の地域別販売量 - メスコポラミン臭化物の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別メスコポラミン臭化物販売量 - 主要メーカー別メスコポラミン臭化物売上 - 主要メーカー別メスコポラミン臭化物価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（5mg、2.5mg、1mg） - メスコポラミン臭化物のタイプ別販売量 - メスコポラミン臭化物のタイプ別売上 - メスコポラミン臭化物のタイプ別価格 ・アプリケーション別市場規模（術後悪心・嘔吐、乗り物酔い、腹痛、過敏性腸症候群、目の炎症、その他） - メスコポラミン臭化物のアプリケーション別販売量 - メスコポラミン臭化物のアプリケーション別売上 - メスコポラミン臭化物のアプリケーション別価格 ・北米市場 - 北米のメスコポラミン臭化物市場規模（タイプ別、アプリケーション別） - 主要国別のメスコポラミン臭化物市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのメスコポラミン臭化物市場規模（タイプ別、アプリケーション別） - 主要国別のメスコポラミン臭化物市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のメスコポラミン臭化物市場規模（タイプ別、アプリケーション別） - 主要国別のメスコポラミン臭化物市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のメスコポラミン臭化物市場規模（タイプ別、アプリケーション別） - 主要国別のメスコポラミン臭化物市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのメスコポラミン臭化物市場規模（タイプ別、アプリケーション別） - 主要国別のメスコポラミン臭化物市場規模（トルコ、サウジアラビア） ・企業情報 Aldo Union、Bayshore Pharma、Beltapharm、Breckenridge Pharma、Novartis、Strides Pharma、Guangzhou Pharmaceutical Group ・産業チェーン及び販売チャネル分析 - メスコポラミン臭化物の産業チェーン分析 - メスコポラミン臭化物の原材料 - メスコポラミン臭化物の生産プロセス - メスコポラミン臭化物の販売及びマーケティング - メスコポラミン臭化物の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - メスコポラミン臭化物の産業動向 - メスコポラミン臭化物のマーケットドライバー - メスコポラミン臭化物の課題 - メスコポラミン臭化物の阻害要因 ・主な調査結果 |
It is a natural or synthetically produced tropane alkaloid and anticholinergic drug that is formally used as a medication for treating motion sickness and postoperative nausea and vomiting
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Methscopolamine Bromide is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Methscopolamine Bromide is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Methscopolamine Bromide is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Methscopolamine Bromide include Aldo Union, Bayshore Pharma, Beltapharm, Breckenridge Pharma, Novartis, Strides Pharma and Guangzhou Pharmaceutical Group, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Methscopolamine Bromide manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Methscopolamine Bromide market. Further, it explains the major drivers and regional dynamics of the global Methscopolamine Bromide market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Aldo Union
Bayshore Pharma
Beltapharm
Breckenridge Pharma
Novartis
Strides Pharma
Guangzhou Pharmaceutical Group
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by specification and by application segments based on sales, price, and value for the period 2017-2028.
Methscopolamine Bromide Segment by Specification
5Mg
2.5Mg
1Mg
Methscopolamine Bromide Segment by Application
Postoperative Nausea and Vomiting
Motion Sickness
Abdominal Cramps
Irritable Bowel Syndrome
Inflammation of the Eyes
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Methscopolamine Bromide market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Methscopolamine Bromide, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Methscopolamine Bromide, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Methscopolamine Bromide, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Methscopolamine Bromide sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Methscopolamine Bromide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Methscopolamine Bromide sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Aldo Union, Bayshore Pharma, Beltapharm, Breckenridge Pharma, Novartis, Strides Pharma and Guangzhou Pharmaceutical Group, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Methscopolamine Bromide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Methscopolamine Bromide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by specification, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by specification, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by specification, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by specification, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by specification, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Methscopolamine Bromide sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Methscopolamine Bromide Product Introduction
1.2 Market by Specification
1.2.1 Global Methscopolamine Bromide Market Size Growth Rate by Specification, 2017 VS 2021 VS 2028
1.2.2 5Mg
1.2.3 2.5Mg
1.2.4 1Mg
1.3 Market by Application
1.3.1 Global Methscopolamine Bromide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Postoperative Nausea and Vomiting
1.3.3 Motion Sickness
1.3.4 Abdominal Cramps
1.3.5 Irritable Bowel Syndrome
1.3.6 Inflammation of the Eyes
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Methscopolamine Bromide Sales Estimates and Forecasts 2017-2028
2.2 Global Methscopolamine Bromide Revenue Estimates and Forecasts 2017-2028
2.3 Global Methscopolamine Bromide Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Methscopolamine Bromide Sales by Region
2.4.1 Global Methscopolamine Bromide Sales by Region (2017-2022)
2.4.2 Global Sales Methscopolamine Bromide by Region (2023-2028)
2.5 Global Methscopolamine Bromide Revenue by Region
2.5.1 Global Methscopolamine Bromide Revenue by Region (2017-2022)
2.5.2 Global Methscopolamine Bromide Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Methscopolamine Bromide Sales by Manufacturers
3.1.1 Global Top Methscopolamine Bromide Manufacturers by Sales (2017-2022)
3.1.2 Global Methscopolamine Bromide Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Methscopolamine Bromide in 2021
3.2 Global Methscopolamine Bromide Revenue by Manufacturers
3.2.1 Global Methscopolamine Bromide Revenue by Manufacturers (2017-2022)
3.2.2 Global Methscopolamine Bromide Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Methscopolamine Bromide Revenue in 2021
3.3 Global Methscopolamine Bromide Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Methscopolamine Bromide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Methscopolamine Bromide Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Specification
4.1 Global Methscopolamine Bromide Sales by Specification
4.1.1 Global Methscopolamine Bromide Historical Sales by Specification (2017-2022)
4.1.2 Global Methscopolamine Bromide Forecasted Sales by Specification (2023-2028)
4.1.3 Global Methscopolamine Bromide Sales Market Share by Specification (2017-2028)
4.2 Global Methscopolamine Bromide Revenue by Specification
4.2.1 Global Methscopolamine Bromide Historical Revenue by Specification (2017-2022)
4.2.2 Global Methscopolamine Bromide Forecasted Revenue by Specification (2023-2028)
4.2.3 Global Methscopolamine Bromide Revenue Market Share by Specification (2017-2028)
4.3 Global Methscopolamine Bromide Price by Specification
4.3.1 Global Methscopolamine Bromide Price by Specification (2017-2022)
4.3.2 Global Methscopolamine Bromide Price Forecast by Specification (2023-2028)
5 Market Size by Application
5.1 Global Methscopolamine Bromide Sales by Application
5.1.1 Global Methscopolamine Bromide Historical Sales by Application (2017-2022)
5.1.2 Global Methscopolamine Bromide Forecasted Sales by Application (2023-2028)
5.1.3 Global Methscopolamine Bromide Sales Market Share by Application (2017-2028)
5.2 Global Methscopolamine Bromide Revenue by Application
5.2.1 Global Methscopolamine Bromide Historical Revenue by Application (2017-2022)
5.2.2 Global Methscopolamine Bromide Forecasted Revenue by Application (2023-2028)
5.2.3 Global Methscopolamine Bromide Revenue Market Share by Application (2017-2028)
5.3 Global Methscopolamine Bromide Price by Application
5.3.1 Global Methscopolamine Bromide Price by Application (2017-2022)
5.3.2 Global Methscopolamine Bromide Price Forecast by Application (2023-2028)
6 North America
6.1 North America Methscopolamine Bromide Market Size by Specification
6.1.1 North America Methscopolamine Bromide Sales by Specification (2017-2028)
6.1.2 North America Methscopolamine Bromide Revenue by Specification (2017-2028)
6.2 North America Methscopolamine Bromide Market Size by Application
6.2.1 North America Methscopolamine Bromide Sales by Application (2017-2028)
6.2.2 North America Methscopolamine Bromide Revenue by Application (2017-2028)
6.3 North America Methscopolamine Bromide Market Size by Country
6.3.1 North America Methscopolamine Bromide Sales by Country (2017-2028)
6.3.2 North America Methscopolamine Bromide Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Methscopolamine Bromide Market Size by Specification
7.1.1 Europe Methscopolamine Bromide Sales by Specification (2017-2028)
7.1.2 Europe Methscopolamine Bromide Revenue by Specification (2017-2028)
7.2 Europe Methscopolamine Bromide Market Size by Application
7.2.1 Europe Methscopolamine Bromide Sales by Application (2017-2028)
7.2.2 Europe Methscopolamine Bromide Revenue by Application (2017-2028)
7.3 Europe Methscopolamine Bromide Market Size by Country
7.3.1 Europe Methscopolamine Bromide Sales by Country (2017-2028)
7.3.2 Europe Methscopolamine Bromide Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Methscopolamine Bromide Market Size by Specification
8.1.1 Asia Pacific Methscopolamine Bromide Sales by Specification (2017-2028)
8.1.2 Asia Pacific Methscopolamine Bromide Revenue by Specification (2017-2028)
8.2 Asia Pacific Methscopolamine Bromide Market Size by Application
8.2.1 Asia Pacific Methscopolamine Bromide Sales by Application (2017-2028)
8.2.2 Asia Pacific Methscopolamine Bromide Revenue by Application (2017-2028)
8.3 Asia Pacific Methscopolamine Bromide Market Size by Region
8.3.1 Asia Pacific Methscopolamine Bromide Sales by Region (2017-2028)
8.3.2 Asia Pacific Methscopolamine Bromide Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Methscopolamine Bromide Market Size by Specification
9.1.1 Latin America Methscopolamine Bromide Sales by Specification (2017-2028)
9.1.2 Latin America Methscopolamine Bromide Revenue by Specification (2017-2028)
9.2 Latin America Methscopolamine Bromide Market Size by Application
9.2.1 Latin America Methscopolamine Bromide Sales by Application (2017-2028)
9.2.2 Latin America Methscopolamine Bromide Revenue by Application (2017-2028)
9.3 Latin America Methscopolamine Bromide Market Size by Country
9.3.1 Latin America Methscopolamine Bromide Sales by Country (2017-2028)
9.3.2 Latin America Methscopolamine Bromide Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Methscopolamine Bromide Market Size by Specification
10.1.1 Middle East and Africa Methscopolamine Bromide Sales by Specification (2017-2028)
10.1.2 Middle East and Africa Methscopolamine Bromide Revenue by Specification (2017-2028)
10.2 Middle East and Africa Methscopolamine Bromide Market Size by Application
10.2.1 Middle East and Africa Methscopolamine Bromide Sales by Application (2017-2028)
10.2.2 Middle East and Africa Methscopolamine Bromide Revenue by Application (2017-2028)
10.3 Middle East and Africa Methscopolamine Bromide Market Size by Country
10.3.1 Middle East and Africa Methscopolamine Bromide Sales by Country (2017-2028)
10.3.2 Middle East and Africa Methscopolamine Bromide Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Aldo Union
11.1.1 Aldo Union Corporation Information
11.1.2 Aldo Union Overview
11.1.3 Aldo Union Methscopolamine Bromide Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Aldo Union Methscopolamine Bromide Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Aldo Union Recent Developments
11.2 Bayshore Pharma
11.2.1 Bayshore Pharma Corporation Information
11.2.2 Bayshore Pharma Overview
11.2.3 Bayshore Pharma Methscopolamine Bromide Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bayshore Pharma Methscopolamine Bromide Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayshore Pharma Recent Developments
11.3 Beltapharm
11.3.1 Beltapharm Corporation Information
11.3.2 Beltapharm Overview
11.3.3 Beltapharm Methscopolamine Bromide Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Beltapharm Methscopolamine Bromide Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Beltapharm Recent Developments
11.4 Breckenridge Pharma
11.4.1 Breckenridge Pharma Corporation Information
11.4.2 Breckenridge Pharma Overview
11.4.3 Breckenridge Pharma Methscopolamine Bromide Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Breckenridge Pharma Methscopolamine Bromide Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Breckenridge Pharma Recent Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Overview
11.5.3 Novartis Methscopolamine Bromide Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novartis Methscopolamine Bromide Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Strides Pharma
11.6.1 Strides Pharma Corporation Information
11.6.2 Strides Pharma Overview
11.6.3 Strides Pharma Methscopolamine Bromide Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Strides Pharma Methscopolamine Bromide Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Strides Pharma Recent Developments
11.7 Guangzhou Pharmaceutical Group
11.7.1 Guangzhou Pharmaceutical Group Corporation Information
11.7.2 Guangzhou Pharmaceutical Group Overview
11.7.3 Guangzhou Pharmaceutical Group Methscopolamine Bromide Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Guangzhou Pharmaceutical Group Methscopolamine Bromide Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Guangzhou Pharmaceutical Group Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Methscopolamine Bromide Industry Chain Analysis
12.2 Methscopolamine Bromide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Methscopolamine Bromide Production Mode & Process
12.4 Methscopolamine Bromide Sales and Marketing
12.4.1 Methscopolamine Bromide Sales Channels
12.4.2 Methscopolamine Bromide Distributors
12.5 Methscopolamine Bromide Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Methscopolamine Bromide Industry Trends
13.2 Methscopolamine Bromide Market Drivers
13.3 Methscopolamine Bromide Market Challenges
13.4 Methscopolamine Bromide Market Restraints
14 Key Findings in The Global Methscopolamine Bromide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer